A Stock You Should Be Looking At: Verona Pharma plc (NASDAQ:VRNA)

After finishing at $22.53 in the prior trading day, Verona Pharma plc (NASDAQ: VRNA) closed at $23.06, up 2.35%. In other words, the price has increased by $+0.53 from its previous closing price. On the day, 531209 shares were traded. VRNA stock price reached its highest trading level at $23.08 during the session, while it also had its lowest trading level at $22.30.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

Our goal is to gain a better understanding of VRNA by taking a closer look at its different ratios.

Upgrades & Downgrades

On August 26, 2022, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $31.

On September 13, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on September 13, 2021, with a $25 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 23 when Gupta Rishi sold 2,170,368 shares for $22.84 per share. The transaction valued at 49,576,607 led to the insider holds 34,085,528 shares of the business.

ORBIMED ADVISORS LLC sold 2,170,368 shares of VRNA for $49,576,607 on Dec 23. The Director now owns 34,085,528 shares after completing the transaction at $22.84 per share. On Dec 22, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, sold 3,969,496 shares for $21.77 each. As a result, the insider received 86,424,249 and left with 36,255,896 shares of the company.

Stock Price History:

Over the past 52 weeks, VRNA has reached a high of $26.44, while it has fallen to a 52-week low of $3.41. The 50-Day Moving Average of the stock is 17.45, while the 200-Day Moving Average is calculated to be 9.81.

Shares Statistics:

The stock has traded on average 906.96K shares per day over the past 3-months and 529.27k shares per day over the last 10 days, according to various share statistics. A total of 68.02M shares are outstanding, with a floating share count of 59.22M. Insiders hold about 10.53% of the company’s shares, while institutions hold 68.56% stake in the company. Shares short for VRNA as of Oct 13, 2022 were 761.47k with a Short Ratio of 1.25M, compared to 626.5k on Sep 14, 2022.

Earnings Estimates

Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.16 for the current quarter, with a high estimate of $0.09 and a low estimate of -$0.33, while EPS last year was $0.16. The consensus estimate for the next quarter is -$0.17, with high estimates of $0.1 and low estimates of -$0.41.

Analysts are recommending an EPS of between -$0.17 and -$1.45 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$1.13, with 4 analysts recommending between -$0.17 and -$2.07.